The Japan Science and Technology Agency has selected eight new projects, including Osaka University and Doshisha University, as 2023 projects for the university-based new industry creation fund project.The project aims to foster startup companies with high corporate value by assigning human resources with commercialization know-how, such as venture capital, to university R&D as promoters and integrating R&D and business development.
According to the Japan Science and Technology Agency, Osaka University's selected project is ``Commercialization of an artificial ribosome platform for next-generation artificial peptide proteins,'' which is being promoted by Professor Wataru Aoki of the Graduate School of Engineering.Promoted by venture capital firm ANRI, the project will commercialize unique synthetic biology technology that can freely modify ribosomes and create artificial peptide proteins that can be applied to industry.
The project selected by Doshisha University is ``Development of the world's first antidote for carbon monoxide poisoning and other antidotes for gas poisoning using this technology'' conducted by Professor Hiroaki Kitagishi of the Faculty of Science and Engineering.Bio Cyto Capital, a public and private company that fosters entrepreneurs, is acting as a promoter and will develop an antidote using a compound that combines with carbon monoxide in the blood and is excreted in the urine.
In addition, research from the University of Tsukuba, Chiba University, Juntendo University, Kyoto University, Kyushu University, and Saga University was selected.
